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ABSTRACT
Fecal microbiota transplantation (FMT) is a highly effective therapy for recurrent Clostridioides
difficile infection. Stool donors are essential, but difficult to recruit and retain. We aimed to
identify factors influencing willingness to donate stool. This multi-center study with a 32-item
questionnaire targeted young adults and health care workers via social media and university email
lists in Edmonton and Kingston, Canada; London and Nottingham, England; and Indianapolis and
Boston, USA. Items included baseline demographics and FMT knowledge and perception.
Investigated motivators and deterrents included economic compensation, screening process,
time commitment, and stool donation logistics. Logistic regression and linear regression models
estimated associations of study variables with self-assessed willingness to donate stool. 802
respondents completed our questionnaire: 387 (48.3%) age 21-30 years, 573 (71.4%) female, 323
(40%) health care workers. Country of residence, age and occupation were not associated with
willingness to donate stool. Factors increasing willingness to donate were: already a blood donor
(OR 1.64), male, altruism, economic benefit, knowledge of how FMT can help patients (OR 1.32),
and positive attitudes towards FMT (OR 1.39). Factors decreasing willingness to donate were: stool
collection unpleasant (OR 0.92), screening process invasive (OR 0.92), higher stool donation
frequency, negative social perception of stool, and logistics of collection/transporting feces. We
conclude that 1) blood donors and males are more willing to consider stool donation; 2) altruism,
economic compensation, and positive feedback are motivators; and 3) screening process, high
donation frequency, logistics of collection/transporting feces, lack of public awareness, and
negative social perception are deterrents. Considering these variables could maximize donor
recruitment and retention.
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Introduction
Clostridioides difficile infection is the most common
global cause of nosocomial diarrhea,1−5 creating an
enormous health-care burden.2-7 Antimicrobials
directed against C. difficile are the mainstay of treat-
ment, but many patients experience recurrences.2,8
Fecal microbiota transplantation (FMT) is a highly
effective therapy for patients with recurrent
C. difficile infection, with a greater than 90% success
rate.9-12 Emerging evidence suggests that FMT may
also have therapeutic benefits in other conditions
associated with perturbed gut microbiota, including
ulcerative colitis,13-16 Crohn’s disease,17 irritable
bowel syndrome,18 metabolic syndrome,19,20 multi-
ple sclerosis,21,22 depression,23 and autism.24,25
Intense interest in FMT is evident, with over 250
clinical trials registered on of January 11, 2019.
A reliable pool of healthy stool donors is essential
for any FMT program, but recruiting and retaining
stool donors are not easy. The rigorous screening
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process and significant time commitment narrow the
donor pool substantially. Studies conducted by public
stool banks have found that 40% of the potential
donors decline screening because of the frequency
and duration of donating.26 Furthermore, donor elig-
ibility screening eliminates over 55% of the potential
donors with history of asthma, allergies, gastrointest-
inal illnesses, autoimmune diseases, antibiotic use in
the past 3 months, recent travel to a tropical country,
or high body mass index.27-29 Additionally, many
potentially eligible candidates are excluded following
blood and stool testing for pathogens.27-29 Only
2–12% of potential candidates successfully pass all
the necessary screening steps.26,28,30,31 An observa-
tional study in Denmark found that this increased to
20%when donors were recruited from a pool of blood
donors.32
Although few studies have explored attitudes
toward stool donation, previous studies on blood,
gamete, and biospecimen donation have examined
motivators and deterrents for potential donors. One
small survey of nine participants investigated attitudes
toward stool donation; four of the participants indi-
cated that the main reason for becoming a donor was
altruism.33 Although altruism has repeatedly been
shown to be the main reason for donating, regardless
of type of donation, economic compensation does
further motivate gamete donors.11,34-40 However,
blood and biospecimen donors viewed monetary
compensation negatively in some studies.34,41 Factors
which deterred people from donating blood and
gametes include anxiety, concerns over adverse events
and pain from phlebotomy or procedures, lack of
information and accessibility, time constraints, nega-
tive perception from others, religious or cultural
beliefs, and impact on future relationships.35,36,39,42-46
Unique challenges for stool donation may include
the embarrassment of donation, logistics of stool
donation, and the lack of public awareness of FMT.
Given the paucity of data on potential motivators and
deterrents for stool donation, the aims of this study
were to (1) assess knowledge of and attitudes toward
FMT and stool donation and (2) identify factors that
may motivate or discourage stool donation.
Results
A total of 802 participants responded to the online
survey. We excluded 17 responses from countries
other than Canada, the United States, and the
United Kingdom. Also seven participants were
excluded who did not indicate their gender on
the questionnaire. This resulted in a total of 782
participants in the analytic sample. Willingness to
donate stool had a median score of 8, with 25th
percentile of 6 and 75th percentile of 10.
Dichotomizing scores as 1–7 and 8–10 yielded
448 (57.6%) participants who were highly willing
to donate stool and 330 (42.4%) participants less
than highly willing to donate stool.
Table 1 shows participant characteristics by
willingness to donate stool. High willingness to
donate did not vary notably by country of origin
or having considered being an organ donor.
Relative to participants who did not indicate high
willingness to donate, among those with high will-
ingness to donate, the proportion female was
slightly lower, the proportion in the youngest age
group was somewhat smaller, the proportion in
the highest age group was somewhat larger, and
the proportion that had donated blood was sub-
stantially greater (59.2% vs. 47.9%, P = 0.002).
Table 2 summarizes other questionnaire
responses by willingness to donate stool. Relative
to participants who did not express high willing-
ness to donate, those with high willingness to
donate scored higher on average on positive atti-
tude toward FMT, and opposition to donating
stool frequently. A larger proportion of those
with high willingness to donate indicated altruism
as the primary reason for stool donation and will-
ingness to receive FMT if medically indicated.
Logistic regression model
The logistic regression model identified several
variables associated with high willingness to
donate stool (Table 3). First, having self-
identified as female gender was associated with
lower odds of being highly willing to donate
stool (odds ratios [OR] = 0.56, 95% confidence
interval [CI]: 0.37–0.85, P = 0.007). Second, the
odds of being highly willing to donate stool were
64% higher for blood donors than for participants
who had not been a blood donor (OR = 1.64, 95%
CI: 1.13–2.37, P = 0.009). Eight other survey vari-
ables were identified as associated with being
highly willing to donate stool. Three of those
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variables could be considered barriers to stool
donation and five were motivators for stool
donation.
Barriers to stool donation
If participants found collecting their own stool
unpleasant, they were less likely to be highly will-
ing to donate stool (OR = 0.92, 95% confidence
interval [CI]: 0.86–0.995, P = 0.037). If participants
felt that having to see a doctor to review medical
history and undergo a physical examination was
invasive, they were less likely to be highly willing
to donate stool (OR = 0.92, 95% CI: 0.84–1.00,
P = 0.05). Those who believed that donating
stool every month was a large commitment were
also less likely to be highly willing to become
a donor (OR = 0.82, 95% CI: 0.76–0.89, P < 0.001).
Motivators for stool donation
Participants who had positive attitudes toward FMT
were more likely to be highly willing to become stool
donors (OR = 1.39, 95% CI: 1.24–1.56, P < 0.001).
Those whoweremore willing to consider stool dona-
tion without economic compensation were more
likely to be highly willing to become a stool donor
(OR = 1.29, 95% CI: 1.17–1.42, P < 0.001). Economic
compensation also increased the likelihood of
becoming a stool donor. Participants who were
more willing to consider stool donation with $5–10
compensation per donation were more likely to be
highly willing to become a stool donor (OR = 1.19,
95% CI: 1.11–1.29, P < 0.001). In other words, people
were highly willing to be a donor even without com-
pensation (altruism) but if compensation was
offered, it was still a motivator (supplementary fig-
ures A and B). If participants felt that helping others
was more important than the inconvenience of
donating, they were more likely to be highly willing
to become a donor (OR = 1.32, 95% CI: 1.19–1.46,
P < 0.001). Also, having a purely or mostly economic
reason for stool donation was associated with
a greater likelihood of be highly willing to be a stool
donor (OR = 2.55, 95% CI: 1.14–5.7, P = 0.022).
Sensitivity analysis by linear regression model
Table 4 shows results from the linear regression
model, consistent with results from the logistic regres-
sion model. Having self-identified as female gender
was again associated with a lower willingness to con-
sider stool donation.Willingness to donate stool aver-
aged 0.39 points lower for females than males on the
10-point Likert scale (95% CI: 0.15–0.64, P = 0.001).
For participants whose primary reason for stool
Table 1. Willingness to become a stool donor, on a scale from 1 (strongly disagree that they are willing) to 10 (strongly agree that
they are willing) by participant characteristics.
High willingness to be a stool donor
Number of participants (total n = 778) No (n = 330) Yes (n = 448) P value
Country 0.41
Canada 311 (40.0%) 123 (37.3%) 188 (42.0%)
United Kingdom 164 (21.1%) 72 (21.8%) 92 (20.5%)
USA 303 (38.9%) 135 (40.9%) 168 (37.5%)
Female gender 565 (72.6%) 249 (75.5%) 316 (70.5%) 0.13
Age (years) 0.14
<21 33 (4.2%) 21 (6.4%) 12 (2.7%)
21–30 377 (48.5%) 160 (48.5%) 217 (48.4%)
31–40 149 (19.2%) 62 (18.8%) 87 (19.4%)
41–50 85 (10.9%) 35 (10.6%) 50 (11.2%)
>50 134 (17.2%) 52 (15.8%) 82 (18.3%)
Occupation 0.83
Health-care professional 320 (41.1%) 138 (41.8%) 182 (40.6%)
Student 240 (30.8%) 96 (29.1%) 144 (32.1%)
University faculty or staff 76 (9.8%) 34 (10.3%) 42 (9.4%)
Other 142 (18.3%) 62 (18.8%) 80 (17.9%)
Blood donors 423 (54.4%) 158 (47.9%) 265 (59.2%) 0.002
Number of blood donations 0.017
0 donations 355 (45.6%) 172 (52.1%) 183 (40.8%)
<10 donations 288 (37.0%) 110 (33.3%) 178 (39.7%)
11–20 donations 87 (11.2%) 32 (9.7%) 55 (12.3%)
>20 donations 48 (6.2%) 16 (4.8%) 32 (7.1%)
Considered being an organ donor 703 (90.4%) 292 (88.5%) 411 (91.7%) 0.13
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Table 2. Summary of survey responses by willingness to become a stool donor.
Highly willing to be
a stool donor
Median survey response and interquartile range
(Likert scale of 1–10)
No
(n = 330)
Yes
(n = 448) P value
Attitude toward FMT
Previous knowledge about FMT and how it could help patients 8.0 (4.0–9.0) 7.0
(2.0–9.0)
8.0
(5.0–10.0)
<0.001
Positive attitude toward FMT 9.0 (8.0–10.0) 8.0
(6.0–9.0)
10.0
(8.0–10.0)
<0.001
Collection of my own stool is unpleasant 5.0 (3.0–8.0) 7.0
(5.0–8.0)
4.0
(2.0–7.0)
<0.001
Time commitment
Having to see a doctor to review my medical history and
undergo a physical examination is invasive
2.0 (1.0–4.0) 3.0
(2.0–5.0)
2.0
(1.0–4.0)
<0.001
Having to do blood/stool tests every 4 months is a reasonable
commitment
7.0 (5.0–8.0) 6.0
(5.0–8.0)
8.0
(6.0–9.0)
<0.001
Becoming a stool donor would be a large commitment for me
to make if I have to
Donate twice a week 8.0 (6.0–10.0) 9.0
(7.0–10.0)
8.0
(6.0–9.0)
<0.001
Donate once a week 7.0 (5.0–9.0) 7.0
(6.0–9.0)
6.0
(4.0–8.0)
<0.001
Donate every 2 weeks 5.0 (3.0–7.0) 6.0
(4.0–8.0)
4.0
(2.0–6.0)
<0.001
Donate every month 3.0 (1.0–5.0) 4.0
(3.0–6.0)
2.0
(1.0–4.0)
<0.001
Economic compensation
Economic compensation is fair to blood donors 5.0 (2.0–7.0) 5.0
(3.0–7.0)
5.0
(2.0–7.0)
0.038
Economic compensation is fair to stool donors 5.0 (3.0–7.0) 5.0
(3.0–7.0)
5.0
(2.0–7.0)
0.013
More likely to become a stool donor if economic compensation
is offered
7.0 (3.0–9.0) 7.0
(4.0–8.0)
7.0
(3.0–9.0)
0.92
Would consider being a stool donor
If there is no economic compensation 6.0 (5.0–8.0) 5.0
(4.0–6.0)
7.0
(6.0–9.0)
<0.001
For $5–10 per donation 5.0 (3.0–7.0) 5.0
(2.0–6.0)
6.0
(4.0–8.0)
<0.001
For $10.01–20 per donation 6.0 (4.0–8.0) 5.0
(3.0–7.0)
7.0
(5.0–9.0)
<0.001
For $20.01–30 per donation 7.0 (5.0–9.0) 7.0
(4.0–8.0)
8.0
(5.0–10.0)
<0.001
For $40 per donation 8.5 (5.0–10.0) 8.0
(5.0–10.0)
9.0
(6.0–10.0)
<0.001
Opinion in terms of a fair amount for each stool donation Number of participants (total n = 778) <0.001
$0 178 (28.1%) 60
(21.8%)
118
(33.0%)
$1–10 91 (14.4%) 27 (9.8%) 64
(17.9%)
$11–20 136 (21.5%) 52
(18.9%)
84
(23.5%)
$21–30 85 (13.4%) 45
(16.4%)
40
(11.2%)
$31–40 84 (13.3%) 53
(19.3%)
31 (8.7%)
$40+ 59 (9.3%) 38
(13.8%)
21 (5.9%)
Motivations for donating
Primary reason for stool donation if choosing to become
a donor
Number of participants (total n = 778) <0.001
Purely altruistic 323 (41.6%) 103
(31.3%)
220
(49.1%)
Mostly altruistic, but also economic 272 (35.0%) 120
(36.5%)
152
(33.9%)
(Continued )
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donation was mostly or purely economic, the willing-
ness to donate stool averaged 0.63 points higher (95%
CI 0.15–1.10; P = 0.011). Similar to the result in the
logistic regression model, potential barriers to dona-
tion were finding stool collection unpleasant, finding
the need to see a physician to qualify as a stool donor
invasive, and finding monthly stool donation fre-
quency to be as large commitment. Potential motiva-
tors were having positive attitudes toward FMT,
knowing that FMT helps others, and economic com-
pensation. An additional motivator identified by the
linear regression model was knowledge of how their
stool donation helps others. In addition, participants
who considered being an organ donor were more
willing to become a stool donor, with their willingness
to be a stool donor averaging 0.49 points higher (95%
CI: 0.12–0.87,P= 0.011). Blood donorswere stillmore
highly willing to be a stool donor (point esti-
mate = 0.19), but the difference in willingness to
Table 2. (Continued).
Highly willing to be
a stool donor
Median survey response and interquartile range
(Likert scale of 1–10)
No
(n = 330)
Yes
(n = 448) P value
Equally altruistic and economic 133 (17.1%) 77
(23.4%)
56
(12.5%)
Mostly economic, but also altruistic 40 (5.1%) 23 (7.0%) 17 (3.8%)
Purely economic 9 (1.2%) 6 (1.8%) 3 (0.7%)
Median survey response and interquartile
range (Likert scale of 1–10)
Helping others is more important to me than any
inconvenience being a stool donor may impose
7.0 (5.0–9.0) 6.0
(5.0–7.0)
8.0
(6.0–9.0)
<0.001
Would like to know how my donations are helping patients
requiring FMT
8.0 (7.0–10.0) 8.0
(6.0–9.0)
9.0
(7.0–10.0)
<0.001
Donor status
Would be willing to receive FMT if becoming sick 9.0 (7.0–10.0) 7.0
(5.0–9.0)
10.0
(8.0–10.0)
<0.001
Table 3. Estimated effects of selected factors on the odds of
being highly willing to donate stool.
OR (95% CI) P value
Self-identifying as female vs. male
gender
0.56 (0.37–0.85) 0.007
Blood donor vs. not a blood donor 1.64 (1.13–2.37) 0.009
Collection of my own stool is unpleasant 0.92 (0.86–0.995) 0.037
Having to see a doctor to review my
medical history and undergo
a physical examination is invasive
0.92 (0.84–1.00) 0.05
Becoming a stool donor would be
a large commitment for me to make if
I have to donate every month
0.82 (0.76–0.89) <0.001
Positive attitude toward FMT 1.39 (1.24–1.56) <0.001
Would consider being a stool donor
without economic compensation
1.29 (1.17–1.42) <0.001
Would consider being a stool donor for
$5–10 per donation
1.19 (1.11–1.29) <0.001
Helping others is more important to me
than any inconvenience being a stool
donor may impose
1.32 (1.19–1.46) <0.001
Primary reason for stool donation is
mostly or purely economic vs. mostly
or purely altruistic or equally
economic and altruistic
2.55 (1.14–5.7) 0.022
Table 4. Results of linear regression model with willingness to
become a stool donor as dependent variable.
Estimate (95% CI) P value
Self-identifying as female vs. male
gender
−0.39 (−0.64, −0.15) 0.002
Considered organ donation vs. not
considered organ donation
0.49 (0.12, 0.87) 0.011
Collection of my own stool is
unpleasant
−0.08 (−0.13, −0.04) <0.001
Having to see a doctor to review my
medical history and undergo
a physical examination is invasive
−0.06 (−0.12, −0.01) 0.017
Becoming a stool donor would be
a large commitment for me to
make if I have to donate every
month
−0.13 (−0.17, −0.08) <0.001
Positive attitude toward FMT 0.27 (0.20, 0.33) <0.001
Economic compensation is fair to
blood donors
0.05 (0.01, 0.10) 0.021
Would consider being a stool donor
without economic compensation
0.25 (0.20, 0.31) <0.001
Would consider being a stool donor
for $20.01–30 per donation
0.12 (0.08, 0.17) <0.001
Helping others is more important to
me than any inconvenience being
a stool donor may impose
0.21 (0.15, 0.27) <0.001
Would like to know how my
donations are helping patients
requiring FMT
0.07 (0.02, 0.12) 0.005
Primary reason for stool donation is
mostly or purely economic vs.
mostly or purely altruistic or
equally economic and altruistic
0.63 (0.15, 1.10) 0.011
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donate stool did not reach statistical significance (95%
CI: −0.03–0.41, P = 0.088).
Qualitative analysis
There were 307 responses to the optional open text
question at the end of the survey: “Are there any
other motivators and/or apprehensions that you
can think of for becoming a stool donor?”
Barriers to stool donation
We identified four themes related to barriers to stool
donation: logistics, social norms, disgust, and risks.
Over 100 participants expressed concerns about the
potential logistical barriers associated with time and
transportation of stool donation, as the following
quote illustrates:
Really the time commitment and location of drop
off for donation would be the biggest factors affect-
ing whether I would donate. Wouldn’t want to have
to drive across the city twice a week, for example.
Concerns of societal stigma, embarrassment, and
awkwardness of stool donation were expressed by
13 participants:
There is a stigma around feces; most people find it
abhorrent and we are not exposed to others’ bowel
movements very often.
The “ick” factor being a deterrent for donating was
commented on by 30 participants:
Would need to get past squeamishness … it’s
not a pleasant subject!
The risks of harmful effects of FMT to the
donor or recipient were a concern for nine
participants:
As for blood transfusion, the concern that the donation
in and of itself could actually do harm to the recipient.
Motivators of stool donation
Three key themes were identified in connection to
motivators to stool donation: altruism, compensa-
tion, and helping family and friends.
Helping those who were ill and contributing to
progress in scientific research were suggested by 38
participants as important reasons to donate stool:
Understanding what it is like for people who require
transplants is enough of a motivator for me to be
a donor.
Just over 20 participants discussed interest in com-
pensation, either economically or in the form of
information about their gut microbiome health.
The following two examples illustrate these differ-
ent approaches to compensation:
the concept of “being paid to take a dump” is quite
attractive.
I am also interested in how healthy my gut is. I’d like
to know the results of any analysis done on my stool.
Many expected that out-of-pocket expenses would
be covered, as this quote demonstrates:
If it’s something that would have to be done often,
I would think money to cover transportation is not
unreasonable.
Donating to family and friends was preferred for
over 20 participants and would be more of
a motivator than donating to strangers:
I am fully aware of the benefits it can bring but it
still feels rather weird. If it was for family, I would
be much more likely to donate.
Personal narratives
A small number of participants provided responses,
one quite lengthy, that outlined a narrative of their
personal experience of family members receiving
FMT. The following two excerpts highlight how
people who have first-hand experience of the impact
of FMT on family and friends can be both knowl-
edgeable and positive about the benefits of FMT.
I have a family member who passed away from
C. diff colitis and had been a recipient of the FMT,
so I’m very passionate about this subject matter….
For patients with other co-morbidities (i.e., elderly
patients with weakened immune systems), the FMT
should be performed during the FIRST infection.
My sister got C. diff after chemo and was hospita-
lized over a month. She received a fecal transplant
after antibiotics were unsuccessful. I think if she
received it earlier, her hospitalization would have
been much shorter.
Discussion
FMT is currently being used primarily as a therapy
for recurrent C. difficile infection. As clinical inter-
est grows in the use of FMT for treating an
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expanding number of medical conditions, so will
the need for healthy donors. Finding donors who
both pass the stringent screening process and are
committed to donating stool on a regular basis is
a significant challenge in setting up a successful
FMT program or stool bank. Unlike other tissue
donation, stool donation is not well known to the
general public and may be embarrassing for poten-
tial donors. To operate a cost-efficient program,
better understanding of why people may consider
stool donation is needed for developing best stra-
tegies to recruit and retain donors.
This is the largest survey of potential FMT donors
to date. Responses collected from six academic insti-
tutions in three countries offer important insights
into the factors that determine the likelihood of suc-
cess in recruiting FMT donors. As with blood,
gamete, and biospecimen donations, we found that
altruism is themain reason individuals consider stool
donation.34-41 Positive attitudes toward FMT, knowl-
edge of how one’s donation is helping others, and
economic compensation may contribute to the deci-
sion to donate. In addition, we found that individuals
who are blood donors and those who considered
organ donation aremore likely to consider becoming
stool donors. These same factorsmay facilitate donor
retention over time. Barriers to stool donation
included lack of knowledge about FMT and actual
logistics of stool donation, both of which are barriers
to blood donation.35,36,42 Higher frequency of stool
donation decreases willingness to donate.
One interesting finding was that survey partici-
pants self-identifying as female gender are less will-
ing to become stool donors. Female gender was
found to be associated with lower odds of having
strong willingness to donate stool, when answers to
the survey were included in the regression model.
However, when we examined the model variables in
more detail, we could not find a compelling reason
or explanation as to why this was the case. Three
factors (related to time commitment, monetary com-
pensation, and altruism) seemed to be a confounder
for gender only when taken together, and none of
these variables taken individually were statistically
significant for gender. Although there are no data
on the influence of gender and willingness to donate
stool, the field of biological donation is very complex.
A recent sociological study of the gendered aspects of
biological donations highlights a variety of cultural
and social complexities that may influence willing-
ness to participate in the donation of biological
material.47 The literature on blood donation also
shows conflicting gender data. In the United
Kingdom, in 2017, a study found that more women
than men donated blood (56.6% vs. 43.4%).48 In
contrast, women only accounted for 30% of blood
donors in Italy and Greece in another study.49
Factors explaining gender difference in Italy
included a greater expectation of trauma, adverse
reactions, or fear of some aspects of the blood collec-
tion process (e.g., vasovagal reactions, dizziness,
bruising at blood draw site, etc. as well as anxiety
over the procedure), as compared to men.49 This
could conceivably apply to stool donation as well
i.e., the screening bloodwork required to test stool
donors for pathogens and communicable diseases on
an ongoing basis may be more of a deterrent for
women donors than for men.We did not specifically
explore this possibility in our survey.We also did not
delve into the specifics of the stool donation process
in our survey or provide details regarding FMT
program/infrastructure available to facilitate stool
donation. For example in Pakistan, a country with
low numbers of women blood donors, a survey of
over 600 women health-care professionals found
83% of them would be more likely to donate blood
if better infrastructure and donation facilities were
available for them to donate at work, on-site.50
Finally, there may be reasons for gender variability
in willingness to donate stool across different cul-
tural and national contexts that were not detected in
our study. While our findings suggest that gender
differences may affect stool donation, more research
is needed to explore this finding in more detail.
Educating the public about FMT, stool donations,
and the clinical potential of FMT should be under-
taken to promote awareness and to decrease negative
perception associated with stool donation. As one
respondent puts it: “there is a stigma around feces;
most people find it abhorrent and we are not
exposed to others’ bowel movements very often.”
As in the previous studies, we found that informing
donors about the benefits of their donation will
motivate them.33 In addition, our data indicate that
monetary incentives canmove peoples’ attitude from
feeling neutral to being willing to donate. The results
of our study are consistent with other studies show-
ing that being a blood donor does improve the
GUT MICROBES 57
likelihood of becoming a stool donor, in part due to
donor familiarity with the blood donation
process.32,33 Most institutions employ an FMT
screening process based on blood donor screening
practices, which uses similar donor screening ques-
tionnaires and serum laboratory testing to screen for
transmissible infectious diseases.
Every aspect of donor screening, stool collection,
and donation drop-off and frequency should be
made as easy and convenient as possible. Previous
studies found that 33–41% of the participants
would decline becoming a stool donor due to fre-
quency and duration of donating.26,33 This was
a common concern of the participants in our
study. To recruit more donors, stool donation
must be made easier for donors by increasing the
number of drop-off locations or decreasing the
required frequency of donation. The donation kit
should be as user-friendly as possible. Another
strategy is for individuals to donate as often as
possible between screenings while their donations
are held in “quarantine.” Providing time away from
stool donation may also minimize donor fatigue.
Our qualitative analysis indicates a possible direc-
tion for more in-depth study, particularly relating to
motivations for stool donation when family or
friends are recipients. A growing body of research
related to clinical care incorporates patient and
family engagement, but few qualitative studies
focus on recruitment for collection of microbial
samples such as feces and urine.51 More research is
needed to understand how collaborations between
clinicians, patients, and family members can help
when recruiting and retaining stool donors.
This study has several strengths. It is multicenter,
multinational, and the largest of its kind. The results
are robust and did not differ among countries.
Analyses were conducted by categorizing willingness
to donate on a 1–10 Likert scale. The study is limited
by surveys being sent out primarily through
a university-affiliated link, with the majority of survey
respondents being health-care workers or students at
the academic institutions. Another study weakness is
the potential of self-selection bias, as the individuals
who respond to surveys may be those who are poten-
tially more interested, motivated and willing to con-
sider donation. This may decrease generalizability of
the results. This survey was only released in English,
limiting the diversity of participants and decreasing
potential applicability to non-English-speaking cen-
ters or countries. The survey only asked individuals
if theywerewilling to become stool donors but did not
ask if theywent through the process of actually becom-
ing a stool donor.
In conclusion, this large multicenter, multina-
tional study has identified important factors which
may motivate or deter people from considering stool
donation. FMT programs and stool banks should
consider strategies which take these variables into
consideration, to maximize effectiveness of future
efforts in stool donor recruitment and retention.
Methods
Study design and variables
We designed a cross-sectional, questionnaire-based
internet survey (Appendix A) to examine the influ-
ence of selected characteristics of potential donors on
willingness to donate stool. We collected respondents’
demographics: age, sex, occupation, and country of
residence. Other characteristics of potential donors
were history of blood donation, consideration for
organ donation, and FMT-related knowledge and
attitudes. Modifiable aspects of stool donation were
also assessed: economic compensation, time commit-
ment, and logistics of stool donation. We then asked
participants to assess their willingness to donate stool.
We also gave them the option of writing additional
comments on any motivators or apprehensions not
included in this questionnaire.
Questionnaire development
The investigators, including gastroenterologists,
infectious disease physicians, and clinical epide-
miologists with expertise in FMT, developed a 32-
item structured questionnaire through an iterative
process. Response options were fixed for 31 ques-
tions, with some statements for which respondents
were asked to indicate degrees of agreement on
a 10-point Likert scale. One question asked for an
open-ended response.
Questionnaire dissemination and participant
recruitment
The questionnaire was formatted for Google
Forms and electronically disseminated through
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six academic centers in Canada, the United
Kingdom, and the United States: University of
Alberta, Queen’s University (Kingston, Canada),
University of Nottingham, Imperial College
London, Indiana University, and Brigham and
Women’s Hospital/Harvard University. The ques-
tionnaire was available for online completion from
June 22 to October 31, 2017. Ethics approval was
obtained from each participating institution.
A web link to the questionnaire was emailed to
students, health-care professionals, and staff
affiliated with the academic centers listed above.
Additionally, survey information was posted on
university and other professional forums, Twitter,
Facebook, and campus news websites. Flyers pro-
moting the survey were posted in and around the
universities, including at grocery stores and coffee
shops. Participants were encouraged to forward
the web link to others.
Statistical analysis
Categorical variables were summarized using fre-
quency distributions. Likert scale responses were
summarized using median and interquartile
range, showing the 25th and 75th percentile of
responses. In our primary analysis, the 10-point
Likert scale for willingness to donate stool was
dichotomized at the median, with responses 8–10
indicating being highly willing to be a donor.
This strategy was based on the assumption that
the degree of agreement with the statement “I’d
be willing to be a stool donor for fecal micro-
biota transplantation.” corresponded with the
degree of willingness to be a stool donor. The
dichotomized analysis assumed that survey par-
ticipants who were highly willing to donate stool
and those who were not are two distinct groups.
The secondary sensitivity analysis was a linear
regression which modeled willingness to donate
as a continuous outcome. The linear regression
model assumed that willingness to donate stool
had a constant linear slope.
Participants who were and were not highly willing
to donate stool, based on our dichotomized analysis,
were compared using Pearson’s chi-square test for
categorical variables and theWilcoxon rank sum test
for Likert scale responses. The logistic regression was
performed to estimate ORs as measures of the influ-
ence of selected factors on willingness to donate
stool. Given the large number of study variables,
variables with an unadjusted p-value of 0.25 or
lower were included in a multivariable logistic
regression model with backward elimination to
select important variables associated with willingness
to donate stool. Adjusted ORs and CIs were esti-
mated using the final model. In the linear regression
model, variables were again selected using backward
elimination. Variables with a two-sided p ≤ 0.05 were
considered to be significant.
Qualitative analysis
Analysis of the one open-ended question about
motivators or apprehensions pertaining to becom-
ing a stool donor was performed with NVivo 11,
a software tool that assists in categorizing, analyz-
ing, and identifying key themes within data. We
identified 24 different themes through an iterative
analysis process and ultimately collapsed them
into 3 main categories.
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